- Home
- VIR vs ABL Comparison
VIR vs ABL Comparison
Compare VIR & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- ABL
- Stock Information
- Founded
- VIR 2016
- ABL 2004
- Country
- VIR United States
- ABL United States
- Employees
- VIR N/A
- ABL N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- ABL Investment Managers
- Sector
- VIR Health Care
- ABL Finance
- Exchange
- VIR Nasdaq
- ABL Nasdaq
- Market Cap
- VIR 706.4M
- ABL 661.9M
- IPO Year
- VIR 2019
- ABL N/A
- Fundamental
- Price
- VIR $4.80
- ABL $6.65
- Analyst Decision
- VIR Strong Buy
- ABL Strong Buy
- Analyst Count
- VIR 11
- ABL 3
- Target Price
- VIR $25.73
- ABL $12.83
- AVG Volume (30 Days)
- VIR 1.5M
- ABL 506.4K
- Earning Date
- VIR 10-30-2025
- ABL 11-06-2025
- Dividend Yield
- VIR N/A
- ABL N/A
- EPS Growth
- VIR N/A
- ABL N/A
- EPS
- VIR N/A
- ABL N/A
- Revenue
- VIR $19,000,000.00
- ABL $161,724,466.00
- Revenue This Year
- VIR N/A
- ABL $77.22
- Revenue Next Year
- VIR $11.08
- ABL $29.93
- P/E Ratio
- VIR N/A
- ABL N/A
- Revenue Growth
- VIR N/A
- ABL 69.56
- 52 Week Low
- VIR $4.16
- ABL $4.60
- 52 Week High
- VIR $14.45
- ABL $10.95
- Technical
- Relative Strength Index (RSI)
- VIR 46.19
- ABL 56.18
- Support Level
- VIR $4.75
- ABL $6.20
- Resistance Level
- VIR $5.39
- ABL $6.80
- Average True Range (ATR)
- VIR 0.30
- ABL 0.30
- MACD
- VIR -0.02
- ABL -0.05
- Stochastic Oscillator
- VIR 5.63
- ABL 45.92
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About ABL Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.